Advanced solid tumor Trials in Zhengzhou, China
Conditions / Advanced solid tumor / Zhengzhou, China
Advanced solid tumor has been the subject of sustained clinical investigation across multiple research sites.
55 total trials for this combination
Showing top 10 of 55 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05598268 | A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. | UNKNOWN | PHASE1/PHASE2 |
| NCT04805307 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 | COMPLETED | PHASE1 |
| NCT05183243 | GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results | UNKNOWN | PHASE1 |
| NCT04282018 | Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab | COMPLETED | PHASE1/PHASE2 |
| NCT05602792 | A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors | UNKNOWN | PHASE1/PHASE2 |
| NCT05253053 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | COMPLETED | PHASE1/PHASE2 |
| NCT05434234 | A Study of YL201 in Patients With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT05935098 | BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors | TERMINATED | PHASE1 |
| NCT05468190 | A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T | UNKNOWN | PHASE1 |
| NCT06589596 | An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors | RECRUITING | PHASE1 |